Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2008
08/20/2008CN100412053C Process for phenylacetic acid derivatives
08/19/2008US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/19/2008US7414140 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
08/19/2008US7414139 Catalytic antioxidants and methods of use
08/19/2008US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants
08/19/2008US7414070 Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions
08/19/2008US7414067 Ophthalmic compositions for treating ocular hypertension
08/19/2008US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
08/19/2008US7413817 4,4′-Bis(carbazol-9-yl)-biphenyl based silicone compound and organic electroluminescent device using the same
08/19/2008CA2311165C Improvements in or relating to electrochemical assays
08/19/2008CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/19/2008CA2102095C Cosmetic composition containing melanin pigments associated with some tocopherols, and process for the protection of skin, hair, mucosae and cosmetic compositions
08/16/2008CA2579119A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
08/14/2008WO2008097930A1 Reverse indoles as 5-lipoxygenase-activating protein (flap) inhibitors
08/14/2008WO2008096791A1 Acylguanidine derivative
08/14/2008WO2008096371A1 Isoindolinone pigments and a method of manufacturing.
08/14/2008WO2008095908A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
08/14/2008WO2008095903A1 New addition salt of n-amino-n'-pentylguanidine, the process for its preparation and use thereof for obtaining tegaserod
08/14/2008WO2008095823A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008WO2008095820A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008WO2008041140A3 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
08/14/2008WO2008039087A3 Indoline derivatives and uses thereof
08/14/2008WO2008024914A3 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
08/14/2008WO2008017074A3 Dyes and precursors and conjugates thereof
08/14/2008US20080194878 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors
08/14/2008US20080194838 Carvedilol
08/14/2008US20080194668 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-benzoic acid; 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-2-chloro-phenylamine; thrombocytopenia; radiation therapy, chemotherapy, immune therapy, cancers, viral infections, and transplants such as bone marrow and stem cell transplants
08/14/2008US20080194667 Compositions For Treating Amyloid Associated Diseases
08/14/2008US20080194597 Platelet adp receptor inhibitors
08/14/2008US20080194565 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases
08/14/2008US20080194553 compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition,in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome
08/14/2008US20080193518 3-[2-(3-tert-Butyl-ureido)-3,3-dimethyl-butyryl]-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid (2-carbamoyl-1-cyclobutylmethyl-2-oxo-ethyl)-amide; Solvent-anti-solvent precipitation; hepatitis C virus protease inhibitors
08/14/2008US20080191611 Composite Material, Light Emitting Element and Light Emitting Device
08/14/2008CA2677995A1 Acylguanidine derivative
08/14/2008CA2676678A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008CA2676268A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008CA2676145A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
08/13/2008EP1956003A2 Process for producing an optically active compound
08/13/2008EP1956002A1 New tegaserod maleate polymorphs and process for their preparation
08/13/2008EP1956001A1 Pharmaceutical for use in the treatment of ureterolithiasis
08/13/2008EP1955998A1 New addition salt of N-amino-N'-pentylguanidine, the process for its preparation and use thereof for obtaining tegaserod
08/13/2008EP1955996A1 7, 9-Substituted tetracycline compounds
08/13/2008EP1955697A1 2-aminobenzamide derivative
08/13/2008EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
08/13/2008EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
08/13/2008EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals
08/13/2008EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP1368305B1 7, 9-substituted tetracycline compounds
08/13/2008CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/13/2008CN101243046A Acylguanidine derivative or salt thereof
08/13/2008CN101243038A Arylamine compound and its synthesis method
08/13/2008CN101239943A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239942A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239941A Process for producing optically active compound
08/13/2008CN101239935A Method for producing phthalocyanine compound and its intermediate, and intermediate compound for the same
08/13/2008CN101239928A Propanoic derivatives for treating lipid metabolism disorder
08/13/2008CN100410241C Indolyl styrene salt compound, high density recording medium including said compound and its preparing method
08/12/2008US7411083 {[((1E)-{4-[3-(4-tert-butylphenoxy)prop-1-ynyl]phenyl}methylidene)amino]oxy}acetic acid; plasminogen activator inhibitor, anticoagulant; venous, arterial, cerebral, and deep vein thrombosis, atrial fibrillation, pulmonary fibrosis, myocardial ischemia, atherosclerotic plaque formation
08/12/2008US7411082 Synthesizing method for compound, and catalyst for synthesis reaction
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause
08/12/2008US7410993 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists
08/12/2008US7410956 Caspase inhibitor prodrugs
08/12/2008CA2322158C Arylphenyl-substituted cyclic keto-enols
08/07/2008WO2008094922A1 Photolabile dinitroindolinyl based compounds
08/07/2008WO2008093686A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
08/07/2008WO2008093350A1 Novel anhydrous crystalline form of carvedilol dihydrogen phosphate
08/07/2008WO2008092873A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092681A1 Ghrelin receptor modulators
08/07/2008WO2008092666A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008WO2008092352A1 Antitumor compounds and their preparation method
08/07/2008US20080188666 Stereoisomers with improved selectivity towards the glucocorticoid receptor; treatment of inflammatory diseases such as chronic obstructive pulmonary disease (COPD), asthma or allergic rhinitis; 4-aryl-1-{[1-(aryl)indazol-4-yl]amino}-2-(trifluoromethyl)pentan-2-ol compounds or corresponding amide
08/07/2008US20080188645 Synthesis of Nitrodibenzylfuran Chromophore For Photodeprotection of Organic Molecules
08/07/2008US20080188542 Novel indole polymorphs
08/07/2008US20080188539 Ramipril-amino acid salts
08/07/2008US20080188532 Indole Compound and Use Thereof
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188473 Indoles Useful in the Treatment of Inflammation
08/07/2008US20080188472 Indole-2-Carboxylic Acid Hydrazides
08/07/2008US20080185555 Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting
08/07/2008CA2675468A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/06/2008EP1953141A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1951772A2 Method for controlled free radical polymerization or copolymerization of methacrylic and/or methacrylate monomers or exclusively methacrylic and/or methacrylate copolymers
08/06/2008EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
08/06/2008EP1951669A1 Acyl indoles, compositions containing such compounds and methods of use
08/06/2008EP1951668A2 Novel process for the preparation of thoc
08/06/2008EP1951667A2 Thrombopoietin activity modulating compounds and methods
08/06/2008EP1951315A2 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
08/06/2008EP1951225A2 3-acylindole derivatives the preparation and the therapeutic use thereof
08/06/2008EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
08/06/2008EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
08/06/2008EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN101238101A 2-(1H-indolylsulfanyl)-aryl amine derivatives
08/06/2008CN101238100A Indole compound, optical filter and optical recording material
08/06/2008CN101236158A Reticular cell detection method and detection device